Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
By M. Kyaw, R. Lynfield, W. Schaffner, A. Craig, J. Hadler, A. Reingold, A. Thomas, L. Harrison, N. Bennett, M. Farley and 6 more. New England Journal of Medicine, 2006
868 citations recorded by the source corpus.
Subfields: Epidemiology, Microbiology
View Paper: https://www.semanticscholar.org/paper/6ad0c610d4b53db7de35267c12fe974e8cdbf728
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Harrison
- C. Lexau
- L. Hicks
- J. Bradley
- J. Hadler
- R. Singleton
- B. Flannery
- M. Moore
Citations in the corpus
- Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. (2007, background): “In 2000, the 7-valent protein-polysaccharide conjugate vaccine (PCV7 [Prevnar]; Wyeth Lederle Vaccines) was licensed for use in infants and young children in the United States and led to a dramatic decrease in the rate of invasive pneumococcal disease [1, 2].”
- Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. (2007, result): “Similarly, in the ABC surveillance, rates of IPD caused by penicillin-nonsusceptible strains and strains nonsusceptible to multiple antibiotics decreased between 1999 and 2004 among children and adults.(42) Although there was an increase in drug-resistant infection caused by non-PCV serotypes (prima”
- Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. (2010, result): “Our data complement the findings of recent studies documenting reductions in meningitis [21], noninvasive pneumonia [22], otitis media [23, 24], and pneumococcal infections resistant to antibiotics [25] after PCV7 introduction.”
- Guidelines for the management of adult lower respiratory tract infections - Full version (2011, neutral): “Since the start of vaccination of children with PCV in the USA in 2000 a marked reduction of IPD has been noted both in the vaccinated cohorts and in adults [534,535].”
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (2011, background): “With the success of the 7-valent pneumococcal vaccine in decreasing invasive pneumococcal infection, a decrease in the degree of penicillin resistance in circulating strains has been documented [194], suggesting that the appropriate dosage of amoxicillin may decrease to that recommended in the preva”